China Resources Sanjiu Medical & Pharmaceutical Co Ltd
SZSE:000999

Watchlist Manager
China Resources Sanjiu Medical & Pharmaceutical Co Ltd Logo
China Resources Sanjiu Medical & Pharmaceutical Co Ltd
SZSE:000999
Watchlist
Price: 46.55 CNY 0.67% Market Closed
Market Cap: 59.8B CNY
Have any thoughts about
China Resources Sanjiu Medical & Pharmaceutical Co Ltd?
Write Note

Balance Sheet

Balance Sheet Decomposition
China Resources Sanjiu Medical & Pharmaceutical Co Ltd

Current Assets 23.2B
Cash & Short-Term Investments 8.6B
Receivables 8.8B
Other Current Assets 5.8B
Non-Current Assets 17.5B
Long-Term Investments 768.3m
PP&E 6.7B
Intangibles 9.2B
Other Non-Current Assets 852.9m
Current Liabilities 12.6B
Accounts Payable 2.4B
Accrued Liabilities 1.4B
Short-Term Debt 1.9B
Other Current Liabilities 6.9B
Non-Current Liabilities 8.2B
Long-Term Debt 1.7B
Other Non-Current Liabilities 6.4B

Balance Sheet
China Resources Sanjiu Medical & Pharmaceutical Co Ltd

Rotate your device to view
Balance Sheet
Currency: CNY
Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
1 140
973
910
1 695
2 473
3 088
3 819
2 403
2 361
6 215
Cash
0
0
0
0
0
0
0
2 403
2 361
6 215
Cash Equivalents
1 140
973
910
1 695
2 473
3 088
3 819
0
0
0
Short-Term Investments
0
0
0
0
0
0
200
1 865
774
1 873
Total Receivables
1 941
2 394
2 788
3 882
4 217
6 044
4 922
5 684
5 913
8 581
Accounts Receivables
542
887
1 346
1 825
2 315
2 758
2 980
3 113
4 087
6 182
Other Receivables
1 399
1 507
1 442
2 057
1 902
3 286
1 942
2 571
1 826
2 399
Inventory
858
911
905
1 105
1 533
1 458
1 762
2 369
2 499
5 112
Other Current Assets
1 184
936
479
161
354
214
223
358
441
740
Total Current Assets
5 123
5 213
5 082
6 844
8 576
10 804
10 925
12 679
11 988
22 522
PP&E Net
2 860
3 124
3 313
3 611
3 599
3 762
3 869
4 447
4 964
6 815
PP&E Gross
2 860
3 124
3 313
3 611
3 599
3 762
3 869
4 447
4 964
6 815
Accumulated Depreciation
1 667
1 834
2 088
2 447
2 413
2 657
2 787
3 139
3 476
3 962
Intangible Assets
1 611
1 764
1 837
1 965
2 039
2 099
2 587
2 649
2 750
4 078
Goodwill
707
1 731
3 142
3 550
3 544
3 354
4 105
4 060
3 995
5 124
Note Receivable
0
0
0
0
0
0
0
10
9
10
Long-Term Investments
212
40
29
23
59
835
192
253
2 939
715
Other Long-Term Assets
154
148
148
203
213
547
332
444
477
884
Other Assets
707
1 731
3 142
3 550
3 544
3 354
4 105
4 060
3 995
5 124
Total Assets
10 667
N/A
12 019
+13%
13 552
+13%
16 195
+20%
18 030
+11%
21 402
+19%
22 010
+3%
24 542
+12%
27 123
+11%
40 148
+48%
Liabilities
Accounts Payable
505
626
574
698
666
729
841
1 189
1 449
2 365
Accrued Liabilities
467
482
655
739
848
983
995
1 119
1 212
1 627
Short-Term Debt
253
299
349
464
910
349
302
515
854
1 903
Current Portion of Long-Term Debt
5
1
0
500
0
0
6
45
61
172
Other Current Liabilities
1 442
1 894
2 209
3 103
3 892
4 839
5 152
5 079
5 097
6 879
Total Current Liabilities
2 671
3 301
3 787
5 504
6 317
6 899
7 295
7 947
8 673
12 947
Long-Term Debt
508
500
500
0
0
0
0
97
156
1 940
Deferred Income Tax
74
99
120
133
133
141
195
199
218
341
Minority Interest
236
102
106
286
341
318
332
461
524
5 295
Other Liabilities
419
445
423
433
412
1 284
460
525
543
658
Total Liabilities
3 907
N/A
4 448
+14%
4 937
+11%
6 357
+29%
7 202
+13%
8 642
+20%
8 283
-4%
9 229
+11%
10 113
+10%
21 181
+109%
Equity
Common Stock
979
979
979
979
979
979
979
979
988
988
Retained Earnings
4 644
5 494
6 545
7 690
8 677
9 941
11 117
12 679
14 297
16 162
Additional Paid In Capital
1 147
1 108
1 101
1 181
1 181
1 844
1 636
1 655
1 797
1 878
Unrealized Security Profit/Loss
0
0
0
0
0
0
0
0
0
2
Treasury Stock
0
0
0
0
0
0
0
0
144
132
Other Equity
10
10
10
11
9
4
5
0
71
73
Total Equity
6 760
N/A
7 572
+12%
8 615
+14%
9 839
+14%
10 828
+10%
12 760
+18%
13 727
+8%
15 313
+12%
17 010
+11%
18 967
+12%
Total Liabilities & Equity
10 667
N/A
12 019
+13%
13 552
+13%
16 195
+20%
18 030
+11%
21 402
+19%
22 010
+3%
24 542
+12%
27 123
+11%
40 148
+48%
Shares Outstanding
Common Shares Outstanding
979
979
979
979
979
979
979
1 273
1 274
1 274

See Also

Discover More